Literature DB >> 23688407

Risk factors for contra-lateral hip fracture in elderly patients with previous hip fracture.

Jun-Dong Chang1, Je-Hyun Yoo, Pradeep Reddy, Sang-Soo Lee, Ji-Hyo Hwang, Tae-Young Kim.   

Abstract

INTRODUCTION: Contra-lateral hip fractures in elderly patients with a previous hip fracture increase the incidence of complications and socioeconomic burden. The purpose of this study was to identify the risk factors that contribute to the occurrence of contra-lateral hip fracture in elderly patients.
MATERIALS AND METHODS: Among 1093 patients treated for a hip fracture, 47 patients sustained a contra-lateral hip fracture. These patients were compared with 141 patients with a unilateral hip fracture (controls).
RESULTS: The incidence of contra-lateral hip fracture was 4.3% among the 1093 patients treated for a hip fracture at our institute. A contra-lateral hip fracture occurred within 2 years of initial fracture in 66%, and subsequently, the annual incidence rate decreased. A similar fracture pattern was noted in 70% of patients who sustained an intertrochanteric fracture. In terms of preoperative factors, respiratory disease (OR 2.57, P=0.032) and visual impairment (OR 2.51, P=0.012) were higher in patients with a contra-lateral hip fracture than in controls, and for postoperative factors, the proportions of patients with postoperative delirium (OR 2.91, P=0.022), late onset of rehabilitation (OR 1.05, P=0.023), and poor ambulatory status at 3 months (OR 1.34, P=0.002) were also significantly higher in patients than in controls.
CONCLUSIONS: Postoperative delirium and underlying visual impairment and respiratory disease could be risk factors of contra-lateral fracture in elderly patients. Early and active rehabilitation after surgery is important to prevent the occurrence of contra-lateral hip fracture in the elderly.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Contra-lateral fracture; Elderly; Hip; Risk factor

Mesh:

Year:  2013        PMID: 23688407     DOI: 10.1016/j.injury.2013.03.034

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  7 in total

1.  Comparison of intramedullary and extramedullary fixation of stable intertrochanteric fractures in the elderly: a prospective randomised controlled trial exploring hidden perioperative blood loss.

Authors:  Leyi Cai; Te Wang; Lu Di; Wei Hu; Jianshun Wang
Journal:  BMC Musculoskelet Disord       Date:  2016-11-15       Impact factor: 2.362

2.  Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  BMC Geriatr       Date:  2016-12-01       Impact factor: 3.921

3.  Sequential Bilateral Hip Fractures in Elderly Patients.

Authors:  Seong-Hwan Woo; Kyung-Soon Park; Ik-Sun Choi; Young-Sub Ahn; Dong-Min Jeong; Taek-Rim Yoon
Journal:  Hip Pelvis       Date:  2020-06-15

Review 4.  Risk Factors for Perioperative Hidden Blood Loss After Intertrochanteric Fracture Surgery in Chinese Patients: A Meta-Analysis.

Authors:  Tao Wang; Junfei Guo; Zhiyong Hou
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-03-11

5.  Risk factors for contralateral hip refractures in patients aged over 80 years with intertrochanteric femoral fractures.

Authors:  Shujun Yu; Chen Li; Yuqiao Zhong; Jiacheng Zang; Zhanzhe Zhou; Song Wang; Yinguang Zhang
Journal:  Front Surg       Date:  2022-09-13

6.  Evaluation of Risk Factors for Second Hip Fractures in Elderly Patients.

Authors:  Sabri Batin; Firat Ozan; Kaan Gurbuz; Semmi Koyuncu; Fatih Vatansever; Erdal Uzun
Journal:  J Clin Med Res       Date:  2018-01-26

7.  Cementless Bipolar Hemiarthroplasty for Low-energy Intracapsular Proximal Femoral Fracture in Elderly East-Asian Patients: A Longitudinal 10-year Follow-up Study.

Authors:  Masanori Nishi; Ichiro Okano; Takatoshi Sawada; Natsuki Midorikawa; Katsunori Inagaki
Journal:  Hip Pelvis       Date:  2019-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.